SR ONE CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | DSGN | 6.53M | $61.22M |
 | ZBIO | 5.04M | $182.92M |
 | ORIC | 4.51M | $37.75M |
 | SPRY | 4.01M | $46.75M |
 | NKTX | 3.33M | $6.17M |
 | ACLX | 2.35M | $153.00M |
 | CRSP | 2.04M | $106.91M |
 | ALMS | 1.96M | $19.13M |
 | MLYS | 1.56M | $56.76M |
 | ENGN | 748K | $6.75M |
 | ORKA | 430K | $13.04M |
 | RARE | 138K | $3.17M |
Design Therapeutics, Inc.
DSGN
Shares Held
6.53M
Value
$61.22M
Zenas BioPharma, Inc.
ZBIO
Shares Held
5.04M
Value
$182.92M
ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
4.51M
Value
$37.75M
ARS Pharmaceuticals, Inc.
SPRY
Shares Held
4.01M
Value
$46.75M
Nkarta, Inc.
NKTX
Shares Held
3.33M
Value
$6.17M
Arcellx, Inc.
ACLX
Shares Held
2.35M
Value
$153.00M
CRISPR Therapeutics AG
CRSP
Shares Held
2.04M
Value
$106.91M
Alumis Inc. Common Stock
ALMS
Shares Held
1.96M
Value
$19.13M
Mineralys Therapeutics, Inc.
MLYS
Shares Held
1.56M
Value
$56.76M
enGene Holdings Inc.
ENGN
Shares Held
748K
Value
$6.75M
Oruka Therapeutics, Inc.
ORKA
Shares Held
430K
Value
$13.04M
Ultragenyx Pharmaceutical Inc.
RARE
Shares Held
138K
Value
$3.17M